Posttransfusion Non‐A, Non‐B Hepatitis after Cardiac Surgery: A Prospective Study

Ran Tur‐Kaspa, Dov Victor Shimon, Meir Shalit, Ruth Adler, Shmuel Shraga, Noga Manny, Abraham Morag, Marcel Eliakim

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Abstract. In a prospective study of 50 recipients of HBsAg‐negative blood who had undergone cardiac surgery, 4 (8%) developed acute non‐A, non‐B hepatitis. The patients who developed hepatitis had received significantly more units of blood or blood products than the patients who had no hepatitis. The incubation period of the disease was 4–13 weeks, 3 patients were asymptomatic with peak alaminotransferase (ALT) levels of 320–497 U/l and 1 patient was jaundiced with a peak ALT of 3,400 U/l. 1 of the patients had high ALT levels after 21 weeks of observation, while 3 patients recovered after 7–10 weeks. It is concluded that non‐A, non‐B posttransfusion hepatitis in Israel is a medical problem similar to that in the USA and that the clinical picture of the disease varies from a mild asymptomatic to a symtomatic and protracted course.

Original languageEnglish
Pages (from-to)312-315
Number of pages4
JournalVox Sanguinis
Volume45
Issue number4
DOIs
StatePublished - Oct 1983
Externally publishedYes

Fingerprint

Dive into the research topics of 'Posttransfusion Non‐A, Non‐B Hepatitis after Cardiac Surgery: A Prospective Study'. Together they form a unique fingerprint.

Cite this